A detailed history of Zeke Capital Advisors, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Zeke Capital Advisors, LLC holds 31,313 shares of CRSP stock, worth $1.28 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
31,313
Previous 34,727 9.83%
Holding current value
$1.28 Million
Previous $2.27 Million 43.94%
% of portfolio
0.08%
Previous 0.17%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$39.19 - $65.67 $133,794 - $224,197
-3,414 Reduced 9.83%
31,313 $1.27 Million
Q2 2022

Aug 09, 2022

BUY
$43.23 - $73.83 $199,463 - $340,651
4,614 Added 15.32%
34,727 $2.11 Million
Q1 2022

May 13, 2022

BUY
$53.19 - $79.24 $328,714 - $489,703
6,180 Added 25.82%
30,113 $1.89 Million
Q4 2021

Feb 14, 2022

BUY
$70.09 - $111.29 $757,252 - $1.2 Million
10,804 Added 82.29%
23,933 $1.81 Million
Q3 2021

Nov 15, 2021

SELL
$110.2 - $156.64 $57,965 - $82,392
-526 Reduced 3.85%
13,129 $1.47 Million
Q2 2021

Aug 16, 2021

BUY
$100.84 - $161.89 $1.38 Million - $2.21 Million
13,655 New
13,655 $2.21 Million

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.19B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Zeke Capital Advisors, LLC Portfolio

Follow Zeke Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zeke Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zeke Capital Advisors, LLC with notifications on news.